Protein folding stress in neurodegenerative diseases: A glimpse into the ER

Current Opinion in Cell Biology

Volumn 23, Issue 2, 2011, Pages 239-252

  Matus, Soledad ^a,b   Glimcher, Laurie H ^c,d   Hetz, Claudio ^a,b,c  

^a UNIVERSITY OF CHILE   (Chile)

^b UNIVERSITY OF CHILE   (Chile)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^d HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MEMBRANE PROTEIN;

DEGENERATIVE DISEASE; ENDOPLASMIC RETICULUM; HUMAN; NEUROPATHOLOGY; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DEGRADATION; PROTEIN FOLDING; REVIEW;

ANIMALS; AUTOPHAGY; ENDOPLASMIC RETICULUM; HUMANS; NEURODEGENERATIVE DISEASES; PROTEIN FOLDING; STRESS, PHYSIOLOGICAL;

EID: 79954425809     PISSN: 09550674     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ceb.2011.01.003     Document Type: Review

References (200)

1. Kopito R.R., Ron D. Conformational disease. Nat Cell Biol 2000, 2:E207-209.
2. Rao R.V., Bredesen D.E. Misfolded proteins, endoplasmic reticulum stress and neurodegeneration. Curr Opin Cell Biol 2004, 16:653-662.
3. Selkoe D.J. Folding proteins in fatal ways. Nature 2003, 426:900-904.
4. Taylor J.P., Hardy J., Fischbeck K.H. Toxic proteins in neurodegenerative disease. Science 2002, 296:1991-1995.
5. Ron D., Walter P. Signal integration in the endoplasmic reticulum unfolded protein response. Nat Rev Mol Cell Biol 2007, 8:519-529.
6. Vembar S.S., Brodsky J.L. One step at a time: endoplasmic reticulum-associated degradation. Nat Rev Mol Cell Biol 2008, 9:944-957.
7. Calfon M., Zeng H., Urano F., Till J.H., Hubbard S.R., Harding H.P., Clark S.G., Ron D. IRE1 couples endoplasmic reticulum load to secretory capacity by processing the XBP-1 mRNA. Nature 2002, 415:92-96.
8. Lee K., Tirasophon W., Shen X., Michalak M., Prywes R., Okada T., Yoshida H., Mori K., Kaufman R.J. IRE1-mediated unconventional mRNA splicing and S2P-mediated ATF6 cleavage merge to regulate XBP1 in signaling the unfolded protein response. Genes Dev 2002, 16:452-466.
9. Yoshida H., Matsui T., Yamamoto A., Okada T., Mori K. XBP1 mRNA is induced by ATF6 and spliced by IRE1 in response to ER stress to produce a highly active transcription factor. Cell 2001, 107:881-891.
10. Hetz C., Bernasconi P., Fisher J., Lee A.H., Bassik M.C., Antonsson B., Brandt G.S., Iwakoshi N.N., Schinzel A., Glimcher L.H., et al. Proapoptotic BAX and BAK modulate the unfolded protein response by a direct interaction with IRE1alpha. Science 2006, 312:572-576.
11. Lisbona F., Rojas-Rivera D., Thielen P., Zamorano S., Todd D., Martinon F., Glavic A., Kress C., Lin J.H., Walter P., et al. BAX inhibitor-1 is a negative regulator of the ER stress sensor IRE1alpha. Mol Cell 2009, 33:679-691.
12. Hetz C., Glimcher L.H. Fine-tuning of the unfolded protein response: assembling the IRE1alpha interactome. Mol Cell 2009, 35:551-561.
13. Hetz CaG L. The UPRosome and XBP-1: mastering secretory cell function. Curr Immunol Rev 2008, 4:1-10.
14. Kim I., Shu C.W., Xu W., Shiau C.W., Grant D., Vasile S., Cosford N.D., Reed J.C. Chemical biology investigation of cell death pathways activated by endoplasmic reticulum stress reveals cytoprotective modulators of ASK1. J Biol Chem 2009, 284:1593-1603.
15. Nishitoh H., Matsuzawa A., Tobiume K., Saegusa K., Takeda K., Inoue K., Hori S., Kakizuka A., Ichijo H. ASK1 is essential for endoplasmic reticulum stress-induced neuronal cell death triggered by expanded polyglutamine repeats. Genes Dev 2002, 16:1345-1355.
16. Urano F., Wang X., Bertolotti A., Zhang Y., Chung P., Harding H.P., Ron D. Coupling of stress in the ER to activation of JNK protein kinases by transmembrane protein kinase IRE1. Science 2000, 287:664-666.
17. Ogata M., Hino S., Saito A., Morikawa K., Kondo S., Kanemoto S., Murakami T., Taniguchi M., Tanii I., Yoshinaga K., et al. Autophagy is activated for cell survival after endoplasmic reticulum stress. Mol Cell Biol 2006, 26:9220-9231.
18. Levine B., Kroemer G. Autophagy in the pathogenesis of disease. Cell 2008, 132:27-42.
19. Blais J.D., Addison C.L., Edge R., Falls T., Zhao H., Wary K., Koumenis C., Harding H.P., Ron D., Holcik M., et al. Perk-dependent translational regulation promotes tumor cell adaptation and angiogenesis in response to hypoxic stress. Mol Cell Biol 2006, 26:9517-9532.
20. Harding H.P., Zhang Y., Ron D. Protein translation and folding are coupled by an endoplasmic-reticulum-resident kinase. Nature 1999, 397:271-274.
21. Ameri K., Harris A.L. Activating transcription factor 4. Int J Biochem Cell Biol 2008, 40:14-21.
22. Harding H.P., Zhang Y., Zeng H., Novoa I., Lu P.D., Calfon M., Sadri N., Yun C., Popko B., Paules R., et al. An integrated stress response regulates amino acid metabolism and resistance to oxidative stress. Mol Cell 2003, 11:619-633.
23. Lange P.S., Chavez J.C., Pinto J.T., Coppola G., Sun C.W., Townes T.M., Geschwind D.H., Ratan R.R. ATF4 is an oxidative stress-inducible, prodeath transcription factor in neurons in vitro and in vivo. J Exp Med 2008, 205:1227-1242.
24. Kouroku Y., Fujita E., Tanida I., Ueno T., Isoai A., Kumagai H., Ogawa S., Kaufman R.J., Kominami E., Momoi T. ER stress (PERK/eIF2alpha phosphorylation) mediates the polyglutamine-induced LC3 conversion, an essential step for autophagy formation. Cell Death Differ 2007, 14:230-239.
25. Rouschop K.M., van den Beucken T., Dubois L., Niessen H., Bussink J., Savelkouls K., Keulers T., Mujcic H., Landuyt W., Voncken J.W., et al. The unfolded protein response protects human tumor cells during hypoxia through regulation of the autophagy genes MAP1LC3B and ATG5. J Clin Invest 2010, 120:127-141.
26. Rzymski T., Milani M., Pike L., Buffa F., Mellor H.R., Winchester L., Pires I., Hammond E., Ragoussis I., Harris A.L. Regulation of autophagy by ATF4 in response to severe hypoxia. Oncogene 2010, 29:4424-4435.
27. Chen X., Shen J., Prywes R. The luminal domain of ATF6 senses endoplasmic reticulum (ER) stress and causes translocation of ATF6 from the ER to the Golgi. J Biol Chem 2002, 277:13045-13052.
28. Haze K., Yoshida H., Yanagi H., Yura T., Mori K. Mammalian transcription factor ATF6 is synthesized as a transmembrane protein and activated by proteolysis in response to endoplasmic reticulum stress. Mol Biol Cell 1999, 10:3787-3799.
29. Hetz C.A. ER stress signaling and the BCL-2 family of proteins: from adaptation to irreversible cellular damage. Antioxid Redox Signal 2007, 9:2345-2355.
30. Schroder M., Kaufman R.J. The mammalian unfolded protein response. Annu Rev Biochem 2005, 74:739-789.
31. Heath-Engel H.M., Chang N.C., Shore G.C. The endoplasmic reticulum in apoptosis and autophagy: role of the BCL-2 protein family. Oncogene 2008, 27:6419-6433.
32. Hetz C., Glimcher L. The daily job of night killers: alternative roles of the BCL-2 family in organelle physiology. Trends Cell Biol 2008, 18:38-44.
33. Xu C., Bailly-Maitre B., Reed J.C. Endoplasmic reticulum stress: cell life and death decisions. J Clin Invest 2005, 115:2656-2664.
34. Lin J.H., Li H., Zhang Y., Ron D., Walter P. Divergent effects of PERK and IRE1 signaling on cell viability. PLoS One 2009, 4:e4170.
35. Marciniak S.J., Yun C.Y., Oyadomari S., Novoa I., Zhang Y., Jungreis R., Nagata K., Harding H.P., Ron D. CHOP induces death by promoting protein synthesis and oxidation in the stressed endoplasmic reticulum. Genes Dev 2004, 18:3066-3077.
36. McCullough K.D., Martindale J.L., Klotz L.O., Aw T.Y., Holbrook N.J. Gadd153 sensitizes cells to endoplasmic reticulum stress by down-regulating Bcl2 and perturbing the cellular redox state. Mol Cell Biol 2001, 21:1249-1259.
37. Puthalakath H., O'Reilly L.A., Gunn P., Lee L., Kelly P.N., Huntington N.D., Hughes P.D., Michalak E.M., McKimm-Breschkin J., Motoyama N., et al. ER stress triggers apoptosis by activating BH3-only protein Bim. Cell 2007, 129:1337-1349.
38. Hotamisligil GS: Endoplasmic reticulum stress and the inflammatory basis of metabolic disease. Cell 2010, 140:900-917.
39. Todd D.J., Lee A.H., Glimcher L.H. The endoplasmic reticulum stress response in immunity and autoimmunity. Nat Rev Immunol 2008, 8:663-674.
40. Kakiuchi C., Iwamoto K., Ishiwata M., Bundo M., Kasahara T., Kusumi I., Tsujita T., Okazaki Y., Nanko S., Kunugi H., et al. Impaired feedback regulation of XBP1 as a genetic risk factor for bipolar disorder. Nat Genet 2003, 35:171-175.
41. Kato T., Kuratomi G., Kato N. Genetics of bipolar disorder. Drugs Today (Barc) 2005, 41:335-344.
42. Kakiuchi C., Ishiwata M., Umekage T., Tochigi M., Kohda K., Sasaki T., Kato T. Association of the XBP1-116C/G polymorphism with schizophrenia in the Japanese population. Psychiatry Clin Neurosci 2004, 58:438-440.
43. Kakiuchi C., Kato T. Lithium response and -116C/G polymorphism of XBP1 in Japanese patients with bipolar disorder. Int J Neuropsychopharmacol 2005, 8:631-632.
44. Kato C., Kakiuchi C., Umekage T., Tochigi M., Kato N., Kato T., Sasaki T. XBP1 gene polymorphism (-116C/G) and personality. Am J Med Genet B Neuropsychiatr Genet 2005, 136B:103-105.
45. Cao Y., Knochel S., Oswald F., Donow C., Zhao H., Knochel W. XBP1 forms a regulatory loop with BMP-4 and suppresses mesodermal and neural differentiation in Xenopus embryos. Mech Dev 2006, 123:84-96.
46. Shim J., Umemura T., Nothstein E., Rongo C. The unfolded protein response regulates glutamate receptor export from the endoplasmic reticulum. Mol Biol Cell 2004, 15:4818-4828.
47. Hayashi A., Kasahara T., Iwamoto K., Ishiwata M., Kametani M., Kakiuchi C., Furuichi T., Kato T. The role of brain-derived neurotrophic factor (BDNF)-induced XBP1 splicing during brain development. J Biol Chem 2007, 282:34525-34534.
48. Murakami T., Hino S.I., Saito A., Imaizumi K. Endoplasmic reticulum stress response in dendrites of cultured primary neurons. Neuroscience 2007, 146:1-8.
49. Hayashi A., Kasahara T., Kametani M., Kato T. Attenuated BDNF-induced upregulation of GABAergic markers in neurons lacking Xbp1. Biochem Biophys Res Commun 2008, 376:758-763.
50. Hoeffer C.A., Klann E. Switching gears: translational mastery of transcription during memory formation. Neuron 2007, 54:186-189.
51. Chen A., Muzzio I.A., Malleret G., Bartsch D., Verbitsky M., Pavlidis P., Yonan A.L., Vronskaya S., Grody M.B., Cepeda I., et al. Inducible enhancement of memory storage and synaptic plasticity in transgenic mice expressing an inhibitor of ATF4 (CREB-2) and C/EBP proteins. Neuron 2003, 39:655-669.
52. Costa-Mattioli M., Gobert D., Harding H., Herdy B., Azzi M., Bruno M., Bidinosti M., Ben Mamou C., Marcinkiewicz E., Yoshida M., et al. Translational control of hippocampal synaptic plasticity and memory by the eIF2alpha kinase GCN2. Nature 2005, 436:1166-1173.
53. Costa-Mattioli M., Gobert D., Stern E., Gamache K., Colina R., Cuello C., Sossin W., Kaufman R., Pelletier J., Rosenblum K., et al. eIF2alpha phosphorylation bidirectionally regulates the switch from short- to long-term synaptic plasticity and memory. Cell 2007, 129:195-206.
54. Nosyreva E., Kavalali E.T. Activity-dependent augmentation of spontaneous neurotransmission during endoplasmic reticulum stress. J Neurosci 2010, 30:7358-7368.
55. Pasinelli P., Brown R.H. Molecular biology of amyotrophic lateral sclerosis: insights from genetics. Nat Rev Neurosci 2006, 7:710-723.
56. Rowland L.P., Shneider N.A. Amyotrophic lateral sclerosis. N Engl J Med 2001, 344:1688-1700.
57. Boillee S., Vande Velde C., Cleveland D.W. ALS: a disease of motor neurons and their nonneuronal neighbors. Neuron 2006, 52:39-59.
58. Cozzolino M., Ferri A., Carri M.T. Amyotrophic lateral sclerosis: from current developments in the laboratory to clinical implications. Antioxid Redox Signal 2008, 10:405-443.
59. Dupuis L., Muller A., Meininger V., Loeffler J.P. Molecular mechanisms of amyotrophic lateral sclerosis: recent contributions from studies in animal models. Rev Neurol (Paris) 2004, 160:35-43.
60. Nassif M., Matus S., Castillo K., Hetz C. Amyotrophic lateral sclerosis pathogenesis: a journey through the secretory pathway. Antioxid Redox Signal 2010, 13:1955-1989.
61. Atkin J.D., Farg M.A., Walker A.K., McLean C., Tomas D., Horne M.K. Endoplasmic reticulum stress and induction of the unfolded protein response in human sporadic amyotrophic lateral sclerosis. Neurobiol Dis 2008, 30:400-407.
62. Hetz C., Thielen P., Matus S., Nassif M., Court F., Kiffin R., Martinez G., Cuervo A.M., Brown R.H., Glimcher L.H. XBP-1 deficiency in the nervous system protects against amyotrophic lateral sclerosis by increasing autophagy. Genes Dev 2009, 23:2294-2306.
63. Ilieva E.V., Ayala V., Jove M., Dalfo E., Cacabelos D., Povedano M., Bellmunt M.J., Ferrer I., Pamplona R., Portero-Otin M. Oxidative and endoplasmic reticulum stress interplay in sporadic amyotrophic lateral sclerosis. Brain 2007, 130:3111-3123.
64. Ito Y., Yamada M., Tanaka H., Aida K., Tsuruma K., Shimazawa M., Hozumi I., Inuzuka T., Takahashi H., Hara H. Involvement of CHOP, an ER-stress apoptotic mediator, in both human sporadic ALS and ALS model mice. Neurobiol Dis 2009, 36:470-476.
65. Sasaki S. Endoplasmic reticulum stress in motor neurons of the spinal cord in sporadic amyotrophic lateral sclerosis. J Neuropathol Exp Neurol 2010, 69:346-355.
66. Bosco D.A., Morfini G., Karabacak N.M., Song Y., Gros-Louis F., Pasinelli P., Goolsby H., Fontaine B.A., Lemay N., McKenna-Yasek D., et al. Wild-type and mutant SOD1 share an aberrant conformation and a common pathogenic pathway in ALS. Nat Neurosci 2010, 13:1396-1403.
67. Atkin J.D., Farg M.A., Turner B.J., Tomas D., Lysaght J.A., Nunan J., Rembach A., Nagley P., Beart P.M., Cheema S.S., et al. Induction of the unfolded protein response in familial amyotrophic lateral sclerosis and association of protein-disulfide isomerase with superoxide dismutase 1. J Biol Chem 2006, 281:30152-30165.
68. Kieran D., Woods I., Villunger A., Strasser A., Prehn J.H. Deletion of the BH3-only protein puma protects motoneurons from ER stress-induced apoptosis and delays motoneuron loss in ALS mice. Proc Natl Acad Sci U S A 2007, 104:20606-20611.
69. Kikuchi H., Almer G., Yamashita S., Guegan C., Nagai M., Xu Z., Sosunov A.A., McKhann G.M., Przedborski S. Spinal cord endoplasmic reticulum stress associated with a microsomal accumulation of mutant superoxide dismutase-1 in an ALS model. Proc Natl Acad Sci U S A 2006, 103:6025-6030.
70. Nagata T., Ilieva H., Murakami T., Shiote M., Narai H., Ohta Y., Hayashi T., Shoji M., Abe K. Increased ER stress during motor neuron degeneration in a transgenic mouse model of amyotrophic lateral sclerosis. Neurol Res 2007, 29:767-771.
71. Nishitoh H., Kadowaki H., Nagai A., Maruyama T., Yokota T., Fukutomi H., Noguchi T., Matsuzawa A., Takeda K., Ichijo H. ALS-linked mutant SOD1 induces ER stress- and ASK1-dependent motor neuron death by targeting Derlin-1. Genes Dev 2008, 22:1451-1464.
72. Saxena S., Cabuy E., Caroni P. A role for motoneuron subtype-selective ER stress in disease manifestations of FALS mice. Nat Neurosci 2009, 12:627-636.
73. Walker A.K., Farg M.A., Bye C.R., McLean C.A., Horne M.K., Atkin J.D. Protein disulphide isomerase protects against protein aggregation and is S-nitrosylated in amyotrophic lateral sclerosis. Brain 2010, 133:105-116.
74. Wootz H., Hansson I., Korhonen L., Lindholm D. XIAP decreases caspase-12 cleavage and calpain activity in spinal cord of ALS transgenic mice. Exp Cell Res 2006, 312:1890-1898.
75. Urushitani M., Ezzi S.A., Matsuo A., Tooyama I., Julien J.P. The endoplasmic reticulum-Golgi pathway is a target for translocation and aggregation of mutant superoxide dismutase linked to ALS. Faseb J 2008, 22:2476-2487.
76. Urushitani M., Sik A., Sakurai T., Nukina N., Takahashi R., Julien J.P. Chromogranin-mediated secretion of mutant superoxide dismutase proteins linked to amyotrophic lateral sclerosis. Nat Neurosci 2006, 9:108-118.
77. Boyce M., Bryant K.F., Jousse C., Long K., Harding H.P., Scheuner D., Kaufman R.J., Ma D., Coen D.M., Ron D., et al. A selective inhibitor of eIF2alpha dephosphorylation protects cells from ER stress. Science 2005, 307:935-939.
78. Shimazawa M., Tanaka H., Ito Y., Morimoto N., Tsuruma K., Kadokura M., Tamura S., Inoue T., Yamada M., Takahashi H., et al. An inducer of VGF protects cells against ER stress-induced cell death and prolongs survival in the mutant SOD1 animal models of familial ALS. PLoS One 2010, 5:e15307.
79. Nishimura A.L., Mitne-Neto M., Silva H.C., Richieri-Costa A., Middleton S., Cascio D., Kok F., Oliveira J.R., Gillingwater T., Webb J., et al. A mutation in the vesicle-trafficking protein VAPB causes late-onset spinal muscular atrophy and amyotrophic lateral sclerosis. Am J Hum Genet 2004, 75:822-831.
80. Gkogkas C., Middleton S., Kremer A.M., Wardrope C., Hannah M., Gillingwater T.H., Skehel P. VAPB interacts with and modulates the activity of ATF6. Hum Mol Genet 2008, 17:1517-1526.
81. Langou K., Moumen A., Pellegrino C., Aebischer J., Medina I., Aebischer P., Raoul C. AAV-mediated expression of wild-type and ALS-linked mutant VAPB selectively triggers death of motoneurons through a Ca2+-dependent ER-associated pathway. J Neurochem 2010, 114:795-809.
82. Teuling E., Ahmed S., Haasdijk E., Demmers J., Steinmetz M.O., Akhmanova A., Jaarsma D., Hoogenraad C.C. Motor neuron disease-associated mutant vesicle-associated membrane protein-associated protein (VAP) B recruits wild-type VAPs into endoplasmic reticulum-derived tubular aggregates. J Neurosci 2007, 27:9801-9815.
83. Suzuki H., Kanekura K., Levine T.P., Kohno K., Olkkonen V.M., Aiso S., Matsuoka M. ALS-linked P56S-VAPB, an aggregated loss-of-function mutant of VAPB, predisposes motor neurons to ER stress-related death by inducing aggregation of co-expressed wild-type VAPB. J Neurochem 2009, 108:973-985.
84. Mackenzie I.R., Rademakers R., Neumann M. TDP-43 and FUS in amyotrophic lateral sclerosis and frontotemporal dementia. Lancet Neurol 2010, 9:995-1007.
85. Neumann M., Sampathu D.M., Kwong L.K., Truax A.C., Micsenyi M.C., Chou T.T., Bruce J., Schuck T., Grossman M., Clark C.M., et al. Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science 2006, 314:130-133.
86. Shan X., Chiang P.M., Price D.L., Wong P.C. Altered distributions of Gemini of coiled bodies and mitochondria in motor neurons of TDP-43 transgenic mice. Proc Natl Acad Sci U S A 2010, 107:16325-16330.
87. Kwiatkowski T.J., Bosco D.A., Leclerc A.L., Tamrazian E., Vanderburg C.R., Russ C., Davis A., Gilchrist J., Kasarskis E.J., Munsat T., et al. Mutations in the FUS/TLS gene on chromosome 16 cause familial amyotrophic lateral sclerosis. Science 2009, 323:1205-1208.
88. Deng H.X., Zhai H., Bigio E.H., Yan J., Fecto F., Ajroud K., Mishra M., Ajroud-Driss S., Heller S., Sufit R., et al. FUS-immunoreactive inclusions are a common feature in sporadic and non-SOD1 familial amyotrophic lateral sclerosis. Ann Neurol 2010, 67:739-748.
89. de Rijk M.C., Launer L.J., Berger K., Breteler M.M., Dartigues J.F., Baldereschi M., Fratiglioni L., Lobo A., Martinez-Lage J., Trenkwalder C., et al. Prevalence of Parkinson's disease in Europe: a collaborative study of population-based cohorts. Neurologic Diseases in the Elderly Research Group. Neurology 2000, 54:S21-23.
90. Klein C., Lohmann-Hedrich K. Impact of recent genetic findings in Parkinson's disease. Curr Opin Neurol 2007, 20:453-464.
91. Conn K.J., Gao W., McKee A., Lan M.S., Ullman M.D., Eisenhauer P.B., Fine R.E., Wells J.M. Identification of the protein disulfide isomerase family member PDIp in experimental Parkinson's disease and Lewy body pathology. Brain Res 2004, 1022:164-172.
92. Hoozemans J.J., van Haastert E.S., Eikelenboom P., de Vos R.A., Rozemuller J.M., Scheper W. Activation of the unfolded protein response in Parkinson's disease. Biochem Biophys Res Commun 2007, 354:707-711.
93. Slodzinski H., Moran L.B., Michael G.J., Wang B., Novoselov S., Cheetham M.E., Pearce R.K., Graeber M.B. Homocysteine-induced endoplasmic reticulum protein (herp) is up-regulated in parkinsonian substantia nigra and present in the core of Lewy bodies. Clin Neuropathol 2009, 28:333-343.
94. Makioka K., Yamazaki T., Fujita Y., Takatama M., Nakazato Y., Okamoto K. Involvement of endoplasmic reticulum stress defined by activated unfolded protein response in multiple system atrophy. J Neurol Sci 2010, 297:60-65.
95. Uehara T., Nakamura T., Yao D., Shi Z.Q., Gu Z., Ma Y., Masliah E., Nomura Y., Lipton S.A. S-nitrosylated protein-disulphide isomerase links protein misfolding to neurodegeneration. Nature 2006, 441:513-517.
96. Smith W.W., Jiang H., Pei Z., Tanaka Y., Morita H., Sawa A., Dawson V.L., Dawson T.M., Ross C.A. Endoplasmic reticulum stress and mitochondrial cell death pathways mediate A53T mutant alpha-synuclein-induced toxicity. Hum Mol Genet 2005, 14:3801-3811.
97. Cooper A.A., Gitler A.D., Cashikar A., Haynes C.M., Hill K.J., Bhullar B., Liu K., Xu K., Strathearn K.E., Liu F., et al. Alpha-synuclein blocks ER-Golgi traffic and Rab1 rescues neuron loss in Parkinson's models. Science 2006, 313:324-328.
98. Gitler A.D., Bevis B.J., Shorter J., Strathearn K.E., Hamamichi S., Su L.J., Caldwell K.A., Caldwell G.A., Rochet J.C., McCaffery J.M., et al. The Parkinson's disease protein alpha-synuclein disrupts cellular Rab homeostasis. Proc Natl Acad Sci U S A 2008, 105:145-150.
99. Ding W.X., Yin X.M. Sorting, recognition and activation of the misfolded protein degradation pathways through macroautophagy and the proteasome. Autophagy 2008, 4:141-150.
100. Sugeno N., Takeda A., Hasegawa T., Kobayashi M., Kikuchi A., Mori F., Wakabayashi K., Itoyama Y. Serine 129 phosphorylation of alpha-synuclein induces unfolded protein response-mediated cell death. J Biol Chem 2008, 283:23179-23188.
101. Imai Y., Soda M., Takahashi R. Parkin suppresses unfolded protein stress-induced cell death through its E3 ubiquitin-protein ligase activity. J Biol Chem 2000, 275:35661-35664.
102. Tsai Y.C., Fishman P.S., Thakor N.V., Oyler G.A. Parkin facilitates the elimination of expanded polyglutamine proteins and leads to preservation of proteasome function. J Biol Chem 2003, 278:22044-22055.
103. Wang H.Q., Imai Y., Kataoka A., Takahashi R. Cell type-specific upregulation of Parkin in response to ER stress. Antioxid Redox Signal 2007, 9:533-542.
104. Kitao Y., Imai Y., Ozawa K., Kataoka A., Ikeda T., Soda M., Nakimawa K., Kiyama H., Stern D.M., Hori O., et al. Pael receptor induces death of dopaminergic neurons in the substantia nigra via endoplasmic reticulum stress and dopamine toxicity, which is enhanced under condition of parkin inactivation. Hum Mol Genet 2007, 16:50-60.
105. Kubota K., Niinuma Y., Kaneko M., Okuma Y., Sugai M., Omura T., Uesugi M., Uehara T., Hosoi T., Nomura Y. Suppressive effects of 4-phenylbutyrate on the aggregation of Pael receptors and endoplasmic reticulum stress. J Neurochem 2006, 97:1259-1268.
106. Marazziti D., Di Pietro C., Golini E., Mandillo S., Matteoni R., Tocchini-Valentini G.P. Macroautophagy of the GPR37 orphan receptor and Parkinson disease-associated neurodegeneration. Autophagy 2009, 5:741-742.
107. Yokota T., Sugawara K., Ito K., Takahashi R., Ariga H., Mizusawa H. Down regulation of DJ-1 enhances cell death by oxidative stress, ER stress, and proteasome inhibition. Biochem Biophys Res Commun 2003, 312:1342-1348.
108. Ramirez A., Heimbach A., Grundemann J., Stiller B., Hampshire D., Cid L.P., Goebel I., Mubaidin A.F., Wriekat A.L., Roeper J., et al. Hereditary Parkinsonism with dementia is caused by mutations in ATP13A2, encoding a lysosomal type 5 P-type ATPase. Nat Genet 2006, 38:1184-1191.
109. Samann J., Hegermann J., von Gromoff E., Eimer S., Baumeister R., Schmidt E. Caenorhabditits elegans LRK-1 and PINK-1 act antagonistically in stress response and neurite outgrowth. J Biol Chem 2009, 284:16482-16491.
110. Holtz W.A., O'Malley K.L. Parkinsonian mimetics induce aspects of unfolded protein response in death of dopaminergic neurons. J Biol Chem 2003, 278:19367-19377.
111. Ryu E.J., Harding H.P., Angelastro J.M., Vitolo O.V., Ron D., Greene L.A. Endoplasmic reticulum stress and the unfolded protein response in cellular models of Parkinson's disease. J Neurosci 2002, 22:10690-10698.
112. Silva R.M., Ries V., Oo T.F., Yarygina O., Jackson-Lewis V., Ryu E.J., Lu P.D., Marciniak S.J., Ron D., Przedborski S., et al. CHOP/GADD153 is a mediator of apoptotic death in substantia nigra dopamine neurons in an in vivo neurotoxin model of Parkinsonism. J Neurochem 2005, 95:974-986.
113. Sado M., Yamasaki Y., Iwanaga T., Onaka Y., Ibuki T., Nishihara S., Mizuguchi H., Momota H., Kishibuchi R., Hashimoto T., et al. Protective effect against Parkinson's disease-related insults through the activation of XBP1. Brain Res 2009, 1257:16-24.
114. Egawa N., Yamamoto K., Inoue H., Hikawa R., Nishi K., Mori K., Takahashi R. The endoplasmic reticulum stress sensor. ATF6{alpha}, protects against neurotoxin-induced dopaminergic neuronal death. J Biol Chem 2010.
115. Holtz W.A., Turetzky J.M., Jong Y.J., O'Malley K.L. Oxidative stress-triggered unfolded protein response is upstream of intrinsic cell death evoked by Parkinsonian mimetics. J Neurochem 2006, 99:54-69.
116. Cattaneo E., Zuccato C., Tartari M. Normal huntingtin function: an alternative approach to Huntington's disease. Nat Rev Neurosci 2005, 6:919-930.
117. van Dellen A., Grote H.E., Hannan A.J. Gene-environment interactions, neuronal dysfunction and pathological plasticity in Huntington's disease. Clin Exp Pharmacol Physiol 2005, 32:1007-1019.
118. Nucifora F.C., Sasaki M., Peters M.F., Huang H., Cooper J.K., Yamada M., Takahashi H., Tsuji S., Troncoso J., Dawson V.L., et al. Interference by huntingtin and atrophin-1 with cbp-mediated transcription leading to cellular toxicity. Science 2001, 291:2423-2428.
119. Rockabrand E., Natalia Slepko A.P., Vidya N.N., Aleksey K., Marsh J.L., Sullivan G.P., Steffan J.S., Sensi S.L., Michels Thompson L. The first 17 amino acids of Huntingtin modulate its sub-cellular localization, aggregation and effects on calcium homeostasis. Hum Mol Genet 2007, 16:61-77.
120. Wyttenbach A., Carmichael J., Swartz J., Furlong R.A., Narain Y., Rankin J., Rubinsztein D.C. Effects of heat shock, heat shock protein 40 (HDJ-2), and proteasome inhibition on protein aggregation in cellular models of Huntington's disease. Proc Natl Acad Sci U S A 2000, 97:2898-2903.
121. Carnemolla A., Fossale E., Agostoni E., Michelazzi S., Calligaris R., De Maso L., Del Sal G., MacDonald M.E., Persichetti F. Rrs1 is involved in endoplasmic reticulum stress response in Huntington disease. J Biol Chem 2009, 284:18167-18173.
122. Duennwald M.L., Lindquist S. Impaired ERAD and ER stress are early and specific events in polyglutamine toxicity. Genes Dev 2008, 22:3308-3319.
123. Kouroku Y., Fujita E., Jimbo A., Kikuchi T., Yamagata T., Momoi M.Y., Kominami E., Kuida K., Sakamaki K., Yonehara S., et al. Polyglutamine aggregates stimulate ER stress signals and caspase-12 activation. Hum Mol Genet 2002, 11:1505-1515.
124. Vidal R., Caballero B., Couve A., Hetz C. Converging pathways in the occurrence of endoplasmic reticulum (ER) stress in Huntington's disease. Curr Mol Med 2011, 11:1-12.
125. Noh J.Y., Lee H., Song S., Kim N.S., Im W., Kim M., Seo H., Chung C.W., Chang J.W., Ferrante R.J., et al. SCAMP5 links endoplasmic reticulum stress to the accumulation of expanded polyglutamine protein aggregates via endocytosis inhibition. J Biol Chem 2009, 284:11318-11325.
126. Cho K.J., Lee B.I., Cheon S.Y., Kim H.W., Kim H.J., Kim G.W. Inhibition of apoptosis signal-regulating kinase 1 reduces endoplasmic reticulum stress and nuclear huntingtin fragments in a mouse model of Huntington disease. Neuroscience 2009, 163:1128-1134.
127. Atwal R.S., Xia J., Pinchev D., Taylor J., Epand R.M., Truant R. Huntingtin has a membrane association signal that can modulate huntingtin aggregation, nuclear entry and toxicity. Hum Mol Genet 2007, 16:2600-2615.
128. Yang H., Liu C., Zhong Y., Luo S., Monteiro M.J., Fang S. Huntingtin interacts with the cue domain of gp78 and inhibits gp78 binding to ubiquitin and p97/VCP. PLoS One 2010, 5:e8905.
129. Fernandez-Fernandez M.R., Ferrer I., Lucas J.J. Impaired ATF6alpha processing, decreased Rheb and neuronal cell cycle re-entry in Huntington's disease. Neurobiol Dis 2011, 41:23-32.
130. Prusiner S.B. Prions. Proc Natl Acad Sci U S A 1998, 95:13363-13383.
131. Vey M., Pilkuhn S., Wille H., Nixon R., DeArmond S.J., Smart E.J., Anderson R.G., Taraboulos A., Prusiner S.B. Subcellular colocalization of the cellular and scrapie prion proteins in caveolae-like membranous domains. Proc Natl Acad Sci U S A 1996, 93:14945-14949.
132. Hetz C.A., Soto C. Stressing out the ER: a role of the unfolded protein response in prion-related disorders. Curr Mol Med 2006, 6:37-43.
133. Pan K.M., Baldwin M., Nguyen J., Gasset M., Serban A., Groth D., Mehlhorn I., Huang Z., Fletterick R.J., Cohen F.E., et al. Conversion of alpha-helices into beta-sheets features in the formation of the scrapie prion proteins. Proc Natl Acad Sci U S A 1993, 90:10962-10966.
134. Brown A.R., Rebus S., McKimmie C.S., Robertson K., Williams A., Fazakerley J.K. Gene expression profiling of the preclinical scrapie-infected hippocampus. Biochem Biophys Res Commun 2005, 334:86-95.
135. Hetz C., Lee A.H., Gonzalez-Romero D., Thielen P., Castilla J., Soto C., Glimcher L.H. Unfolded protein response transcription factor XBP-1 does not influence prion replication or pathogenesis. Proc Natl Acad Sci U S A 2008, 105:757-762.
136. Hetz C., Russelakis-Carneiro M., Maundrell K., Castilla J., Soto C. Caspase-12 and endoplasmic reticulum stress mediate neurotoxicity of pathological prion protein. Embo J 2003, 22:5435-5445.
137. Hetz C., Russelakis-Carneiro M., Walchli S., Carboni S., Vial-Knecht E., Maundrell K., Castilla J., Soto C. The disulfide isomerase Grp58 is a protective factor against prion neurotoxicity. J Neurosci 2005, 25:2793-2802.
138. Rane N.S., Kang S.W., Chakrabarti O., Feigenbaum L., Hegde R.S. Reduced translocation of nascent prion protein during ER stress contributes to neurodegeneration. Dev Cell 2008, 15:359-370.
139. Steele A.D., Hetz C., Yi C.H., Jackson W.S., Borkowski A.W., Yuan J., Wollmann R.H., Lindquist S. Prion pathogenesis is independent of caspase-12. Prion 2007, 1:243-247.
140. Yoo B.C., Krapfenbauer K., Cairns N., Belay G., Bajo M., Lubec G. Overexpressed protein disulfide isomerase in brains of patients with sporadic Creutzfeldt-Jakob disease. Neurosci Lett 2002, 334:196-200.
141. Xu K., Wang X., Shi Q., Chen C., Tian C., Li X.L., Zhou R.M., Chu Y.L., Dong X.P. Human prion protein mutants with deleted and inserted octarepeats undergo different pathways to trigger cell apoptosis. J Mol Neurosci 2011, 43:225-234.
142. Apodaca J., Kim I., Rao H. Cellular tolerance of prion protein PrP in yeast involves proteolysis and the unfolded protein response. Biochem Biophys Res Commun 2006, 347:319-326.
143. Hetz C., Castilla J., Soto C. Perturbation of endoplasmic reticulum homeostasis facilitates prion replication. J Biol Chem 2007, 282:12725-12733.
144. Orsi A., Fioriti L., Chiesa R., Sitia R. Conditions of endoplasmic reticulum stress favor the accumulation of cytosolic prion protein. J Biol Chem 2006, 281:30431-30438.
145. Ma J., Lindquist S. Conversion of PrP to a self-perpetuating PrPSc-like conformation in the cytosol. Science 2002, 298:1785-1788.
146. Yedidia Y., Horonchik L., Tzaban S., Yanai A., Taraboulos A. Proteasomes and ubiquitin are involved in the turnover of the wild-type prion protein. Embo J 2001, 20:5383-5391.
147. Citron M. Alzheimer's disease: treatments in discovery and development. Nat Neurosci 2002, 5(Suppl):1055-1057.
148. Haass C., Selkoe D.J. Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid beta-peptide. Nat Rev Mol Cell Biol 2007, 8:101-112.
149. Nakagawa T., Zhu H., Morishima N., Li E., Xu J., Yankner B.A., Yuan J. Caspase-12 mediates endoplasmic-reticulum-specific apoptosis and cytotoxicity by amyloid-beta. Nature 2000, 403:98-103.
150. Hitomi J., Katayama T., Eguchi Y., Kudo T., Taniguchi M., Koyama Y., Manabe T., Yamagishi S., Bando Y., Imaizumi K., et al. Involvement of caspase-4 in endoplasmic reticulum stress-induced apoptosis and Abeta-induced cell death. J Cell Biol 2004, 165:347-356.
151. Hoozemans J.J., van Haastert E.S., Nijholt D.A., Rozemuller A.J., Eikelenboom P., Scheper W. The unfolded protein response is activated in pretangle neurons in Alzheimer's disease hippocampus. Am J Pathol 2009, 174:1241-1251.
152. Hoozemans J.J., Veerhuis R., Van Haastert E.S., Rozemuller J.M., Baas F., Eikelenboom P., Scheper W. The unfolded protein response is activated in Alzheimer's disease. Acta Neuropathol 2005, 110:165-172.
153. Scheper W., Hoozemans J.J., Hoogenraad C.C., Rozemuller A.J., Eikelenboom P., Baas F. Rab6 is increased in Alzheimer's disease brain and correlates with endoplasmic reticulum stress. Neuropathol Appl Neurobiol 2007, 33:523-532.
154. Honjo Y., Ito H., Horibe T., Takahashi R., Kawakami K. Protein disulfide isomerase-immunopositive inclusions in patients with Alzheimer disease. Brain Res 2010, 1349:90-96.
155. Lee J.H., Won S.M., Suh J., Son S.J., Moon G.J., Park U.J., Gwag B.J. Induction of the unfolded protein response and cell death pathway in Alzheimer's disease, but not in aged Tg2576 mice. Exp Mol Med 2010, 42:386-394.
156. Chafekar S.M., Zwart R., Veerhuis R., Vanderstichele H., Baas F., Scheper W. Increased Abeta1-42 production sensitizes neuroblastoma cells for ER stress toxicity. Curr Alzheimer Res 2008, 5:469-474.
157. De Felice F.G., Velasco P.T., Lambert M.P., Viola K., Fernandez S.J., Ferreira S.T., Klein W.L. Abeta oligomers induce neuronal oxidative stress through an N-methyl-d-aspartate receptor-dependent mechanism that is blocked by the Alzheimer drug memantine. J Biol Chem 2007, 282:11590-11601.
158. Ferreiro E., Oliveira C.R., Pereira C. Involvement of endoplasmic reticulum Ca2+ release through ryanodine and inositol 1,4,5-triphosphate receptors in the neurotoxic effects induced by the amyloid-beta peptide. J Neurosci Res 2004, 76:872-880.
159. Kaneko M, Koike H, Saito R, Kitamura Y, Okuma Y, Nomura Y: Loss of HRD1-mediated protein degradation causes amyloid precursor protein accumulation and amyloid-beta generation. J Neurosci 2010, 30:3924-3932.
160. Kosuge Y., Sakikubo T., Ishige K., Ito Y. Comparative study of endoplasmic reticulum stress-induced neuronal death in rat cultured hippocampal and cerebellar granule neurons. Neurochem Int 2006, 49:285-293.
161. Lee do Y., Lee K.S., Lee H.J., Kim do H., Noh Y.H., Yu K., Jung H.Y., Lee S.H., Lee J.Y., Youn Y.C., et al. Activation of PERK signaling attenuates Abeta-mediated ER stress. PLoS One 2010, 5:e10489.
162. Nishitsuji K., Tomiyama T., Ishibashi K., Ito K., Teraoka R., Lambert M.P., Klein W.L., Mori H. The E693Delta mutation in amyloid precursor protein increases intracellular accumulation of amyloid beta oligomers and causes endoplasmic reticulum stress-induced apoptosis in cultured cells. Am J Pathol 2009, 174:957-969.
163. Resende R., Ferreiro E., Pereira C., Oliveira C.R. ER stress is involved in Abeta-induced GSK-3beta activation and tau phosphorylation. J Neurosci Res 2008, 86:2091-2099.
164. Song S., Lee H., Kam T.I., Tai M.L., Lee J.Y., Noh J.Y., Shim S.M., Seo S.J., Kong Y.Y., Nakagawa T., et al. E2-25K/Hip-2 regulates caspase-12 in ER stress-mediated Abeta neurotoxicity. J Cell Biol 2008, 182:675-684.
165. Wiley J.C., Meabon J.S., Frankowski H., Smith E.A., Schecterson L.C., Bothwell M., Ladiges W.C. Phenylbutyric acid rescues endoplasmic reticulum stress-induced suppression of APP proteolysis and prevents apoptosis in neuronal cells. PLoS One 2010, 5:e9135.
166. Ghribi O., Herman M.M., Savory J. Lithium inhibits Abeta-induced stress in endoplasmic reticulum of rabbit hippocampus but does not prevent oxidative damage and tau phosphorylation. J Neurosci Res 2003, 71:853-862.
167. Heinitz K., Beck M., Schliebs R., Perez-Polo J.R. Toxicity mediated by soluble oligomers of beta-amyloid(1-42) on cholinergic SN56.B5.G4 cells. J Neurochem 2006, 98:1930-1945.
168. Ghribi O., Herman M.M., DeWitt D.A., Forbes M.S., Savory J. Abeta(1-42) and aluminum induce stress in the endoplasmic reticulum in rabbit hippocampus, involving nuclear translocation of gadd 153 and NF-kappaB. Brain Res Mol Brain Res 2001, 96:30-38.
169. Ghribi O., Herman M.M., Pramoonjago P., Spaulding N.K., Savory J. GDNF regulates the A beta-induced endoplasmic reticulum stress response in rabbit hippocampus by inhibiting the activation of gadd 153 and the JNK and ERK kinases. Neurobiol Dis 2004, 16:417-427.
170. Selwood S.P., Parvathy S., Cordell B., Ryan H.S., Oshidari F., Vincent V., Yesavage J., Lazzeroni L.C., Murphy G.M. Gene expression profile of the PDAPP mouse model for Alzheimer's disease with and without Apolipoprotein E. Neurobiol Aging 2009, 30:574-590.
171. Sano R., Annunziata I., Patterson A., Moshiach S., Gomero E., Opferman J., Forte M., d'Azzo A. GM1-ganglioside accumulation at the mitochondria-associated ER membranes links ER stress to Ca(2+)-dependent mitochondrial apoptosis. Mol Cell 2009, 36:500-511.
172. Tessitore A., del P.M.M., Sano R., Ma Y., Mann L., Ingrassia A., Laywell E.D., Steindler D.A., Hendershot L.M., d'Azzo A. GM1-ganglioside-mediated activation of the unfolded protein response causes neuronal death in a neurodegenerative gangliosidosis. Mol Cell 2004, 15:753-766.
173. Wei H., Kim S.J., Zhang Z., Tsai P.C., Wisniewski K.E., Mukherjee A.B. ER and oxidative stresses are common mediators of apoptosis in both neurodegenerative and non-neurodegenerative lysosomal storage disorders and are alleviated by chemical chaperones. Hum Mol Genet 2008, 17:469-477.
174. Zhang Z., Lee Y.C., Kim S.J., Choi M.S., Tsai P.C., Xu Y., Xiao Y.J., Zhang P., Heffer A., Mukherjee A.B. Palmitoyl-protein thioesterase-1 deficiency mediates the activation of the unfolded protein response and neuronal apoptosis in INCL. Hum Mol Genet 2006, 15:337-346.
175. Farfel-Becker T., Vitner E., Dekel H., Leshem N., Enquist I.B., Karlsson S., Futerman A.H. No evidence for activation of the unfolded protein response in neuronopathic models of Gaucher disease. Hum Mol Genet 2009, 18:1482-1488.
176. Klein A., Mosqueira M., Martinez G., Robledo F., González M., Caballero B., Cancino G., Alvarez A., Hetz C., Zanlungo S. Lack of activation of the Unfolded Protein Response (UPR) in mouse and cellular models of Niemann-Pick type C disease. Neurodeg Dis 2011, 8:124-128.
177. Aufenberg C., Wenkel S., Mautes A., Paschen W. Spinal cord trauma activates processing of xbp1 mRNA indicative of endoplasmic reticulum dysfunction. J Neurotrauma 2005, 22:1018-1024.
178. Penas C., Guzman M.S., Verdu E., Fores J., Navarro X., Casas C. Spinal cord injury induces endoplasmic reticulum stress with different cell-type dependent response. J Neurochem 2007, 102:1242-1255.
179. Wan S., Shi P., Zhang X., Gu C., Fan S. Stronger expression of CHOP and caspase 12 in diabetic spinal cord injury rats. Neurol Res 2009, 31:1049-1055.
180. Yamauchi T., Sakurai M., Abe K., Matsumiya G., Sawa Y. Impact of the endoplasmic reticulum stress response in spinal cord after transient ischemia. Brain Res 2007, 1169:24-33.
181. Mizukami T., Orihashi K., Herlambang B., Takahashi S., Hamaishi M., Okada K., Sueda T. Sodium 4-phenylbutyrate protects against spinal cord ischemia by inhibition of endoplasmic reticulum stress. J Vasc Surg 2010, 52:1580-1586.
182. Lin W., Popko B. Endoplasmic reticulum stress in disorders of myelinating cells. Nat Neurosci 2009, 12:379-385.
183. Lees J.R., Cross A.H. A little stress is good: IFN-gamma, demyelination, and multiple sclerosis. J Clin Invest 2007, 117:297-299.
184. Lin W., Harding H.P., Ron D., Popko B. Endoplasmic reticulum stress modulates the response of myelinating oligodendrocytes to the immune cytokine interferon-gamma. J Cell Biol 2005, 169:603-612.
185. Lin W., Kemper A., Dupree J.L., Harding H.P., Ron D., Popko B. Interferon-gamma inhibits central nervous system remyelination through a process modulated by endoplasmic reticulum stress. Brain 2006, 129:1306-1318.
186. Lin W., Kunkler P.E., Harding H.P., Ron D., Kraig R.P., Popko B. Enhanced integrated stress response promotes myelinating oligodendrocyte survival in response to interferon-gamma. Am J Pathol 2008, 173:1508-1517.
187. Mhaille A.N., McQuaid S., Windebank A., Cunnea P., McMahon J., Samali A., FitzGerald U. Increased expression of endoplasmic reticulum stress-related signaling pathway molecules in multiple sclerosis lesions. J Neuropathol Exp Neurol 2008, 67:200-211.
188. Ramagopalan S.V., Dobson R., Meier U.C., Giovannoni G. Multiple sclerosis: risk factors, prodromes, and potential causal pathways. Lancet Neurol 2010, 9:727-739.
189. Pennuto M., Tinelli E., Malaguti M., Del Carro U., D'Antonio M., Ron D., Quattrini A., Feltri M.L., Wrabetz L. Ablation of the UPR-mediator CHOP restores motor function and reduces demyelination in Charcot-Marie-Tooth 1B mice. Neuron 2008, 57:393-405.
190. Southwood C.M., Garbern J., Jiang W., Gow A. The unfolded protein response modulates disease severity in Pelizaeus-Merzbacher disease. Neuron 2002, 36:585-596.
191. Kantor L., Harding H.P., Ron D., Schiffmann R., Kaneski C.R., Kimball S.R., Elroy-Stein O. Heightened stress response in primary fibroblasts expressing mutant eIF2B genes from CACH/VWM leukodystrophy patients. Hum Genet 2005, 118:99-106.
192. Kantor L., Pinchasi D., Mintz M., Hathout Y., Vanderver A., Elroy-Stein O. A point mutation in translation initiation factor 2B leads to a continuous hyper stress state in oligodendroglial-derived cells. PLoS One 2008, 3:e3783.
193. Gorbatyuk M.S., Knox T., LaVail M.M., Gorbatyuk O.S., Noorwez S.M., Hauswirth W.W., Lin J.H., Muzyczka N., Lewin A.S. Restoration of visual function in P23H rhodopsin transgenic rats by gene delivery of BiP/Grp78. Proc Natl Acad Sci U S A 2010, 107:5961-5966.
194. Kang M.J., Ryoo H.D. Suppression of retinal degeneration in Drosophila by stimulation of ER-associated degradation. Proc Natl Acad Sci U S A 2009, 106:17043-17048.
195. Lin J.H., Li H., Yasumura D., Cohen H.R., Zhang C., Panning B., Shokat K.M., Lavail M.M., Walter P. IRE1 signaling affects cell fate during the unfolded protein response. Science 2007, 318:944-949.
196. Mendes C.S., Levet C., Chatelain G., Dourlen P., Fouillet A., Dichtel-Danjoy M.L., Gambis A., Ryoo H.D., Steller H., Mollereau B. ER stress protects from retinal degeneration. Embo J 2009, 28:1296-1307.
197. Ryoo H.D., Domingos P.M., Kang M.J., Steller H. Unfolded protein response in a Drosophila model for retinal degeneration. Embo J 2007, 26:242-252.
198. Bonapace G., Waheed A., Shah G.N., Sly W.S. Chemical chaperones protect from effects of apoptosis-inducing mutation in carbonic anhydrase IV identified in retinitis pigmentosa 17. Proc Natl Acad Sci U S A 2004, 101:12300-12305.
199. Datta R., Waheed A., Bonapace G., Shah G.N., Sly W.S. Pathogenesis of retinitis pigmentosa associated with apoptosis-inducing mutations in carbonic anhydrase IV. Proc Natl Acad Sci U S A 2009, 106:3437-3442.
200. Rebello G., Ramesar R., Vorster A., Roberts L., Ehrenreich L., Oppon E., Gama D., Bardien S., Greenberg J., Bonapace G., et al. Apoptosis-inducing signal sequence mutation in carbonic anhydrase IV identified in patients with the RP17 form of retinitis pigmentosa. Proc Natl Acad Sci U S A 2004, 101:6617-6622.